Multiple gastric neuroendocrine tumors in a patient with parietal cell dysfunction and adenosine triphosphatase H+/K+ transporting subunit alpha gene variant
Clinical Journal of Gastroenterology · 2024
DOI: 10.1007/s12328-024-01969-0 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Journal of Gastroenterology, 2024. Verfasst von Yu Sasaki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Gastroenterology, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan. y-sasaki@med.id.yamagata-u.ac.…. Hauptthemen laut MEDLINE: Parietal Cells, Gastric, Stomach Neoplasms, Neuroendocrine Tumors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
A 47-year-old woman presented with multiple gastric tumors, each up to 10 mm in diameter, in the gastric body and fundus without mucosal atrophy. White spots and numerous transparent, light-brownish, small, and rounded spots were observed in the background gastric mucosa. Biopsy specimens obtained from the tumors revealed gastric neuroendocrine tumors. The patient exhibited hypergastrinemia and achlorhydria and tested negative for serum parietal cell antibody, intrinsic factor antibody, and Helicobacter pylori infection. Moreover, no additional lesions were detected on imaging. These findings were inconsistent with Rindi's classification. The tumor was resected via endoscopic submucosal resection. Histopathological examination revealed gastric neuroendocrine tumors G2 infiltrating the submucosa with no atrophy of the gastric mucosa, dilated fundic glands, parietal cell protrusions, and hyperplasia of enterochromaffin-like cells. Immunohistochemically, the parietal cells were negative for both α- and β-subunits of H+/K+ ATPase, suggesting parietal cell dysfunction. A genomic variant was identified in adenosine triphosphatase H+/K+ transporting subunit alpha. After 7 years of treatment, there was no evidence of residual or metastatic lesions. Modification of adenosine triphosphatase H+/K+ transporting subunit alpha may be a significant factor in the pathogenesis of multiple gastric neuroendocrine tumors in the context of gastric parietal cell dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Department of Gastroenterology, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan. y-sasaki@med.id.yamagata-u.ac.jp.
- Division of Endoscopy, Yamagata University Hospital, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.
- Department of General Internal Medicine 2, Kawasaki Medical School General Medical Center, 2‑6‑1, Nakasange, Kitaku, Okayama, 700‑8505, Japan.
- Division of Multi-Omics Research, Yamagata University Well-Being Institute, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.
- Faculty of Medicine, Department of Gastroenterology, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.
Zitieren
APA
Sasaki, Y., Abe, Y., Haruma, K., Sato, H., Yagi, M., Mizumoto, N., Onozato, Y., Ito, M., Watabe, T., & Ueno, Y. (2024). Multiple gastric neuroendocrine tumors in a patient with parietal cell dysfunction and adenosine triphosphatase H+/K+ transporting subunit alpha gene variant. Clinical Journal of Gastroenterology. https://doi.org/10.1007/s12328-024-01969-0
Vancouver
Sasaki Y, Abe Y, Haruma K, Sato H, Yagi M, Mizumoto N, et al. Multiple gastric neuroendocrine tumors in a patient with parietal cell dysfunction and adenosine triphosphatase H+/K+ transporting subunit alpha gene variant. Clinical Journal of Gastroenterology. 2024. doi:10.1007/s12328-024-01969-0
BibTeX
@article{Sasaki2024,
author = {Sasaki, Yu and Abe, Yasuhiko and Haruma, Ken and Sato, Hidenori and Yagi, Makoto and Mizumoto, Naoko and Onozato, Yusuke and Ito, Minami and Watabe, Takahiro and Ueno, Yoshiyuki},
title = {Multiple gastric neuroendocrine tumors in a patient with parietal cell dysfunction and adenosine triphosphatase H+/K+ transporting subunit alpha gene variant},
journal = {Clinical Journal of Gastroenterology},
year = {2024},
doi = {10.1007/s12328-024-01969-0}
}
EUVIMED